Atria Investments
FBIO icon

Atria Investments’s Fortress Biotech FBIO Stock Holding History

Atria Investments’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-88,810
Closed -$165K – 2053
2025
Q2 		$165K Sell
88,810
-11,208
-11% -$19.4K ﹤0.01% 1939
2025
Q1 		$156K Buy
100,018
+11,693
+13% +$20.6K ﹤0.01% 1850
2024
Q4 		$179K Buy
88,325
+16,841
+24% +$30.5K ﹤0.01% 1797
2024
Q3 		$103K Buy
71,484
+26,351
+58% +$50.2K ﹤0.01% 1872
2024
Q2 		$77.2K Buy
+45,133
New +$81.8K ﹤0.01% 1883

Other funds holding FBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Summit Financial
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Sculptor Capital
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
Kestra Advisory Services
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HB Wealth Management
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

Atria Investments's FBIO Position: Q3 2025 in Review

Atria Investments sold out of Fortress Biotech (FBIO) in Q3 2025, closing a stake of 88,810 shares — an estimated $165K sold.

Atria Investments first reported a position in FBIO in Q2 2024 and held it in 5 quarters. The position peaked at $179K in Q4 2024. 56 funds tracked by Wall St. Rank hold FBIO as of Q3 2025.

  • Atria Investments reported no remaining Fortress Biotech position as of Q3 2025 after selling out during the quarter.
  • Atria Investments sold 88,810 Fortress Biotech shares in Q3 2025, an estimated $165K.
  • Atria Investments first reported a position in Fortress Biotech in Q2 2024 and held it in 5 quarters.
  • Atria Investments's Fortress Biotech position peaked at $179K in Q4 2024.
  • 56 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2025.

Based on Atria Investments's 13F filing for Q3 2025, filed 6 Nov 2025.